Invus Public Equities Advisors, LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Invus Public Equities Advisors, LLC
CIK #0001340096
CIK Period
0001340096
Sector Form 13F Holdings Value ($B)
CAVA Group Inc 2.2
Lexicon Pharmaceuticals Inc/DE 0.3
Arrowhead Research Corp 0.1
Scholar Rock Holding Corp 0.1
Kymera Therapeutics Inc 0.1
Apellis Pharmaceuticals Inc 0.1
Dyne Therapeutics Inc 0.1
Silence Therapeutics PLC 0.1
Crinetics Pharmaceuticals Inc 0.0
Merus NV 0.0
BeiGene Ltd 0.0
Revolution Medicines Inc 0.0
Zeta Acquisition Corp III 0.0
Vera Therapeutics Inc 0.0
Neumora Therapeutics Inc 0.0
Cytokinetics Inc 0.0
Avidity Biosciences Inc 0.0
IGM Biosciences Inc 0.0
Wave Life Sciences Ltd 0.0
Erasca Inc 0.0
BCTG Acquisition Corp 0.0
Prothena Corp PLC 0.0
Centessa Pharmaceuticals PLC 0.0
Cullinan Oncology Inc 0.0
Newamsterdam Pharma Co NV 0.0
Xenon Pharmaceuticals Inc 0.0
Edgewise Therapeutics Inc 0.0
Solid Biosciences Inc 0.0
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2025
13F-NT [0001340096]
3 [0001340096]
4 [0001340096]
Form 3/4/5 Subject 2011 - 2025
Scholar Rock Holding Corp
Debbane Raymond
Invus Public Equities, L.P.
Invus Public Equities Advisors, LLC
Invus Global Management, LLC
Siren, L.L.C.
Crescent Biopharma Inc
Artal International S.C.A.
Artal Group S.A.
Artal International Management S.A.
View All
Terms | Privacy | Guide
tony@aum13f.com